Table 4.

Multivariate analysis results on the association between Oct-4 expression and non-SLN metastases

Variables	OR	95 % CI	P
Age	1.032	0.964–1.105	0.359
ER	0.512	0.035–7.411	0.623
PR	0.397	0.061–2.606	0.336
CerbB2	0.775	0.141–4.258	0.770
P53	2.893	0.546–15.32	0.212
Oct-4	7.880	1.164–53.344	0.034*

OR Odds Ratio; *P < 0.05